Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
Gastroenterology
; 162(4): 1210-1225, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-34951993
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Non-alcoholic Fatty Liver Disease
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Gastroenterology
Year:
2022
Document type:
Article